3,3'-diaminobenzidine has been researched along with Carcinoma, Epidermoid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fang, YR; Hata, S; Tanaka, A; Wato, M; Xuan, M | 1 |
Ansai, S; Aoki, T; Hozumi, Y; Kondo, S; Koseki, S; Mitsuhashi, Y | 1 |
2 other study(ies) available for 3,3'-diaminobenzidine and Carcinoma, Epidermoid
Article | Year |
---|---|
Immunohistochemical co-localization of lymphatics and blood vessels in oral squamous cell carcinomas.
Topics: 3,3'-Diaminobenzidine; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD34; Biomarkers, Tumor; Blood Vessels; Carcinoma, Squamous Cell; Coloring Agents; Female; Hemangioma; Humans; Immunohistochemistry; Indoles; Lymphangioma; Lymphatic Vessels; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Nitroblue Tetrazolium | 2005 |
An immunohistochemical study of E-cadherin expression in human squamous cell carcinoma of the skin: relationship between decreased expression of E-cadherin in the primary lesion and regional lymph node metastasis.
Topics: 3,3'-Diaminobenzidine; Antibodies, Monoclonal; Cadherins; Carcinoma, Squamous Cell; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lymphatic Metastasis; Prognosis; Skin Neoplasms | 1999 |